Normal view MARC view ISBD view

Hwang, C

Prospects and limitations of recombinant poxviruses for prostate cancer immunotherapy. [electronic resource] - Current opinion in molecular therapeutics Aug 1999 - 471-9 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review

ISSN: 1464-8431

Subjects--Topical Terms:
Adenocarcinoma--immunology
Animals
Antibodies, Viral--immunology
Antigen Presentation
Antigens, Neoplasm--genetics
Autoimmunity
B7-1 Antigen--genetics
Canarypox virus--genetics
Cancer Vaccines--administration & dosage
Cell Compartmentation
Clinical Trials as Topic
Combined Modality Therapy
Cytokines--genetics
DNA, Recombinant--genetics
Fowlpox virus--genetics
Genetic Therapy--methods
Genetic Vectors--administration & dosage
Humans
Immunotherapy--methods
Immunotherapy, Active
Male
Mice
Mice, Transgenic
Neoplasm Metastasis
Neoplasm Transplantation
Poxviridae--genetics
Promoter Regions, Genetic--genetics
Prostatic Neoplasms--immunology
Rats
Recombinant Fusion Proteins--immunology
Salvage Therapy
Self Tolerance
Smallpox Vaccine--immunology
Species Specificity
Vaccination
Vaccinia--genetics
Viral Vaccines--administration & dosage